🩺
🌍 Worldwide
🏆 #1 · 🩺 Medicine & HealthEfficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials
Most-Cited Alzheimer's Disease Papers This Year
Citations of papers published this year
2The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial•
3TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism•
4Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy•
See full top 10 →